All Stories

  1. The Association between Statins Intake and Risk of Post Stroke Pneumonia: A Systematic Review and Meta-Analysis

    Article • Current Reviews in Clinical and Experimental Pharmacology, August 2024, Bentham Science Publishers

    Dr Catherine Sherwin

  2. The Analgesic Effect of Ginger on Postoperative Pain: A Systematic Review of Clinical Trials

    Article • The Natural Products Journal, March 2024, Bentham Science Publishers

    Dr Catherine Sherwin

  3. Effect and Mechanism of Curcumin on Bone Loss and Osteoporosis: A Systematic Review

    Article • Current Traditional Medicine, December 2023, Bentham Science Publishers

    Dr Catherine Sherwin

  4. A Systematic Review and Meta-analysis on the Role of Statins in the Prevention of Mortality Following Pancreatic Cancer

    Article • Anti-Cancer Agents in Medicinal Chemistry, November 2023, Bentham Science Publishers

    Dr Catherine Sherwin

  5. The Role of Vitamin D in Carpal Tunnel Syndrome Risk and Supplementation Outcomes: A Systematic Review

    Article • Current Rheumatology Reviews, August 2023, Bentham Science Publishers

    Dr Catherine Sherwin

  6. Effect of Curcumin on Oxidative Stress, Inflammatory Response and Kidney Biochemical Parameters Among Kidney Disease Patients: A Systematic Review

    Article • The Natural Products Journal, August 2023, Bentham Science Publishers

    Dr Catherine Sherwin

  7. The Effect of Inhalation Aromatherapy on Patients with Cardiovascular Disease Seeking Pain Relief: A Systematic Review and Meta-analysis

    Article • Current Drug Therapy, June 2023, Bentham Science Publishers

    Dr Catherine Sherwin, Razieh Mohammadi

  8. Investigation into the reproducibility of the association of cord blood magnesium concentration and cerebral palsy or death in children

    Article • March 2020, Research Square

    Dr Catherine Sherwin

  9. Therapeutic Potential of Citrulline as an Arginine Supplement: A Clinical Pharmacology Review

    Article • Pediatric Drugs, March 2020, Springer Science + Business Media

    Dr Catherine Sherwin

  10. Generic drug products in paediatrics: Where are the data?

    Article • British Journal of Clinical Pharmacology, July 2019, Wiley

    Dr Catherine Sherwin

  11. Glucocorticoids pharmacology and their application in the treatment of childhood-onset systemic lupus erythematosus

    Article • Seminars in Arthritis and Rheumatism, March 2019, Elsevier

    Dr Catherine Sherwin

  12. The clinical utility of pharmacometric models

    Article • British Journal of Clinical Pharmacology, May 2018, Wiley

    Dr Catherine Sherwin, Dr Shaun S Kumar

  13. Evident bias in a paracetamol metabolite population pharmacokinetic model applied to an external dataset

    Article • British Journal of Clinical Pharmacology, April 2018, Wiley

    Dr Catherine Sherwin

  14. Clinical Pharmacokinetics of Amikacin in Pediatric Patients: A Comprehensive Review of Population Pharmacokinetic Analyses

    Article • Clinical Pharmacokinetics, March 2018, Springer Science + Business Media

    Dr Catherine Sherwin

  15. Inclusion of pregnant and breastfeeding women in research - efforts and initiatives

    Article • British Journal of Clinical Pharmacology, October 2017, Wiley

    Dr Catherine Sherwin

  16. Predicting tacrolimus concentrations in children receiving a heart transplant using a population pharmacokinetic model

    Article • BMJ Paediatrics Open, October 2017, BMJ

    Dr Catherine Sherwin, Dr Shaun S Kumar

  17. The Need for Pediatric Drug Development

    Article • The Journal of Pediatrics, September 2017, Elsevier

    Dr Catherine Sherwin

  18. Riding (High) into the danger zone: a review of potential differences in chemical exposures in fighter pilots resulting from high altitude and G-forces

    Article • Expert Opinion on Drug Metabolism & Toxicology, August 2017, Taylor & Francis

    Dr Catherine Sherwin

  19. Can ad hoc analyses of clinical trials help personalize treatment decisions?

    Article • British Journal of Clinical Pharmacology, August 2017, Wiley

    Dr Shaun S Kumar, Dr Catherine Sherwin, Shaun Kumar

  20. Population Pharmacokinetic Model of Transdermal Nicotine Delivered from a Matrix-Type Patch

    Article • British Journal of Clinical Pharmacology, August 2017, Wiley

    Dr Catherine Sherwin

  21. Analgesics commonly used to treat pediatric patients with malignancy.

    Article • Expert Opinion on Drug Metabolism & Toxicology, June 2017, Taylor & Francis

    Dr Catherine Sherwin

  22. Newborns still lack drug data to guide therapy

    Article • British Journal of Clinical Pharmacology, October 2016, Wiley

    Dr Catherine Sherwin

  23. Calls to a teratogen information service regarding potential exposures in pregnancy and breastfeeding

    Article • BMC Pharmacology and Toxicology, July 2016, Springer Science + Business Media

    Dr Catherine Sherwin

  24. Salivary caffeine concentrations are comparable to plasma concentrations in preterm infants receiving extended caffeine therapy

    Article • British Journal of Clinical Pharmacology, June 2016, Wiley

    Dr Catherine Sherwin

  25. Unanswered Questions Regarding Optimal Pediatric Vancomycin Use

    Article • Therapeutic Drug Monitoring, June 2016, Wolters Kluwer Health

    Dr Catherine Sherwin

  26. Neonatal Maturation of Paracetamol (Acetaminophen) Glucuronidation, Sulfation, and Oxidation Based on a Parent–Metabolite Population Pharmacokinetic Model

    Article • Clinical Pharmacokinetics, May 2016, Springer Science + Business Media

    Dr Catherine Sherwin

  27. Herbal medicines: challenges in the modern world. Part 1. Australia and New Zealand

    Article • Expert Review of Clinical Pharmacology, April 2016, Taylor & Francis

    Dr Catherine Sherwin

  28. Neonates and medicines: a roadmap to further improve neonatal pharmaceutical care

    Article • European Journal of Pediatrics, January 2016, Springer Science + Business Media

    Dr Catherine Sherwin, Professor karel allegaert

  29. Therapeutic Drug Monitoring in Pregnancy

    Article • January 2016, Elsevier

    Dr Catherine Sherwin

  30. Pregnancy-induced changes in the pharmacokinetics of caffeine and its metabolites

    Article • The Journal of Clinical Pharmacology, December 2015, Wiley

    Dr Catherine Sherwin

  31. Renal Function Descriptors in Neonates: Which Creatinine-Based Formula Best Describes Vancomycin Clearance?

    Article • The Journal of Clinical Pharmacology, December 2015, Wiley

    Dr Catherine Sherwin

  32. Towards Rational Dosing Algorithms for Vancomycin in Neonates and Infants Based on Population Pharmacokinetic Modeling

    Article • Antimicrobial Agents and Chemotherapy, December 2015, ASM Journals

    Dr Catherine Sherwin, Professor karel allegaert

  33. Evaluation of Vancomycin Use in Late-Onset Neonatal Sepsis Using the Area Under the Concentration–Time Curve to the Minimum Inhibitory Concentration ≥400 Target

    Article • Therapeutic Drug Monitoring, December 2015, Wolters Kluwer Health

    Dr Catherine Sherwin

  34. Pharmacokinetic considerations in the use of antivirals in neonates

    Article • Expert Opinion on Drug Metabolism & Toxicology, November 2015, Informa Healthcare

    Dr Catherine Sherwin

  35. Use of Modeling and Simulation in the Design and Conduct of Pediatric Clinical Trials and the Optimization of Individualized Dosing Regimens

    Article • CPT Pharmacometrics & Systems Pharmacology, November 2015, Wiley

    Dr Catherine Sherwin

  36. A propensity-matched cohort study of vancomycin-associated nephrotoxicity in neonates

    Article • Archives of Disease in Childhood Fetal & Neonatal, September 2015, BMJ

    Dr Catherine Sherwin

  37. A Population Pharmacokinetic Analysis of Dextroamphetamine in the Plasma and Hair of Healthy Adults

    Article • Clinical Drug Investigation, September 2015, Springer Science + Business Media

    Dr Catherine Sherwin

  38. Challenges Associated with Route of Administration in Neonatal Drug Delivery

    Article • Clinical Pharmacokinetics, August 2015, Springer Science + Business Media

    Dr Catherine Sherwin

  39. Effect of CYP3A5*3 on asthma control among children treated with inhaled beclomethasone

    Article • Journal of Allergy and Clinical Immunology, August 2015, Elsevier

    Dr Catherine Sherwin

  40. Population Pharmacokinetics of Intravenous Paracetamol (Acetaminophen) in Preterm and Term Neonates: Model Development and External Evaluation

    Article • Clinical Pharmacokinetics, July 2015, Springer Science + Business Media

    Professor karel allegaert , Dr Catherine Sherwin

  41. Pharmacokinetic modeling of therapies for systemic lupus erythematosus

    Article • Expert Review of Clinical Pharmacology, July 2015, Taylor & Francis

    Dr Catherine Sherwin

  42. National Trends in the Incidence, Outcomes and Charges of Pediatric Osteoarticular Infections, 1997–2012

    Article • The Pediatric Infectious Disease Journal, June 2015, Wolters Kluwer Health

    Dr Catherine Sherwin

  43. Quantitative Assay Validation for Oxandrolone in Human Plasma Using LC–MS-MS

    Article • Journal of Analytical Toxicology, May 2015, Oxford University Press (OUP)

    Dr Catherine Sherwin

  44. Darbepoetin administration to neonates undergoing cooling for encephalopathy: a safety and pharmacokinetic trial

    Article • Pediatric Research, May 2015, Springer Science + Business Media

    Dr Catherine Sherwin

  45. Population Pharmacokinetics of Darbepoetin Alfa in Conjunction with Hypothermia for the Treatment of Neonatal Hypoxic-Ischemic Encephalopathy

    Article • Clinical Pharmacokinetics, May 2015, Springer Science + Business Media

    Dr Catherine Sherwin

  46. Application of a method used to deconstruct a single dose pharmacokinetic profile from multiple dose data

    Article • Biopharmaceutics & Drug Disposition, April 2015, Wiley

    Dr Catherine Sherwin

  47. Special population considerations and regulatory affairs for clinical research

    Article • Clinical Research and Regulatory Affairs, April 2015, Taylor & Francis

    Dr Catherine Sherwin

  48. Clinical Pharmacokinetics of Inhaled Antimicrobials

    Article • Clinical Pharmacokinetics, March 2015, Springer Science + Business Media

    Dr Catherine Sherwin

  49. Optimal design in pediatric pharmacokinetic and pharmacodynamic clinical studies

    Article • Pediatric Anesthesia, January 2015, Wiley

    Dr Catherine Sherwin

  50. Determination of Optimal Amikacin Dosing Regimens for Pediatric Patients With Burn Wound Sepsis

    Article • Journal of Burn Care & Research, January 2015, Oxford University Press (OUP)

    Dr Catherine Sherwin

  51. Relationship Between Zolpidem Concentrations and Sleep Parameters in Pediatric Burn Patients

    Article • Journal of Burn Care & Research, January 2015, Oxford University Press (OUP)

    Dr Catherine Sherwin

  52. An extensive pharmacokinetic, metabolic and toxicological review of elderly patients under intensive chemotherapy for acute myeloid leukemia

    Article • Expert Opinion on Drug Metabolism & Toxicology, December 2014, Informa Healthcare

    Dr Catherine Sherwin

  53. Clinical pharmacokinetics and pharmacodynamics of ganciclovir and valganciclovir in children with cytomegalovirus infection

    Article • Expert Opinion on Drug Metabolism & Toxicology, November 2014, Informa Healthcare

    Dr Catherine Sherwin

  54. Levofloxacin inhalation solution for the treatment of chronicPseudomonas aeruginosainfection among patients with cystic fibrosis

    Article • Expert Review of Respiratory Medicine, November 2014, Taylor & Francis

    Dr Catherine Sherwin

  55. Pediatric vancomycin dosing: Trends over time and the impact of therapeutic drug monitoring

    Article • The Journal of Clinical Pharmacology, November 2014, Wiley

    Dr Catherine Sherwin

  56. Illustrative neonatal cases regarding drug delivery issues

    Article • Journal of Paediatrics and Child Health, November 2014, Wiley

    Dr Catherine Sherwin

  57. Ethics of Drug Studies in the Newborn

    Article • Pediatric Drugs, October 2014, Springer Science + Business Media

    Dr Catherine Sherwin

  58. Development of an optimal sampling schedule for children receiving ketamine for short-term procedural sedation and analgesia

    Article • Pediatric Anesthesia, September 2014, Wiley

    Dr Catherine Sherwin

  59. Intrapartum Magnesium Sulfate and the Potential for Cardiopulmonary Drug–Drug Interactions

    Article • Therapeutic Drug Monitoring, August 2014, Wolters Kluwer Health

    Dr Catherine Sherwin

  60. Epidemiological Evaluation of Blood Culture Patterns among Neonates Receiving Vancomycin

    Article • Indian Journal of Microbiology, June 2014, Springer Science + Business Media

    Dr Catherine Sherwin

  61. Preliminary Assessment of Zolpidem Pharmacokinetics in Pediatric Burn Patients

    Article • Therapeutic Drug Monitoring, June 2014, Wolters Kluwer Health

    Dr Catherine Sherwin

  62. Pharmacokinetics and Pharmacodynamics of Antibacterials, Antifungals, and Antivirals Used Most Frequently in Neonates and Infants

    Article • Clinical Pharmacokinetics, May 2014, Springer Science + Business Media

    Dr Catherine Sherwin

  63. Pharmacokinetics and Pharmacodynamics of Antifungals in Children and their Clinical Implications

    Article • Clinical Pharmacokinetics, March 2014, Springer Science + Business Media

    Dr Catherine Sherwin

  64. Amikacin population pharmacokinetics among paediatric burn patients

    Article • Burns, March 2014, Elsevier

    Dr Catherine Sherwin

  65. Alignment of United States funding for cardiovascular disease research with deaths, years of life lost, and hospitalizations

    Article • International Journal of Cardiology, March 2014, Elsevier

    Dr Catherine Sherwin

  66. Evolution of interventional vancomycin trials in light of new antibiotic development in the USA, 1999–2012

    Article • International Journal of Antimicrobial Agents, March 2014, Elsevier

    Dr Catherine Sherwin

  67. Utilization of Optimal Study Design for Maternal and Fetal Sheep Propofol Pharmacokinetics Study: A Preliminary Study

    Article • Current Clinical Pharmacology, February 2014, Bentham Science Publishers

    Dr Catherine Sherwin

  68. Intravenous drug delivery in neonates: lessons learnt

    Article • Archives of Disease in Childhood, January 2014, BMJ

    Dr Catherine Sherwin

  69. Pharmacokinetic and pharmacodynamic optimisation of intravenous tobramycin dosing among children with cystic fibrosis

    Article • Journal of Pharmacokinetics and Pharmacodynamics, January 2014, Springer Science + Business Media

    Dr Catherine Sherwin

  70. Maternal Magnesium Sulphate Exposure Predicts Neonatal Magnesium Blood Concentrations

    Article • Basic & Clinical Pharmacology & Toxicology, December 2013, Wiley

    Dr Catherine Sherwin

  71. Development of levofloxacin inhalation solution to treat Pseudomonas aeruginosa in patients with cystic fibrosis

    Article • Therapeutic Advances in Respiratory Disease, December 2013, SAGE Publications

    Dr Catherine Sherwin

  72. Absence of P-Glycoprotein Transport in the Pharmacokinetics and Toxicity of the Herbicide Paraquat

    Article • Journal of Pharmacology and Experimental Therapeutics, December 2013, American Society for Pharmacology & Experimental Therapeutics (ASPET)

    Dr Catherine Sherwin

  73. Characteristics and publication patterns of obstetric studies registered in ClinicalTrials.gov

    Article • The Journal of Clinical Pharmacology, November 2013, Wiley

    Dr Catherine Sherwin

  74. Considerations in the Pharmacologic Treatment and Prevention of Neonatal Sepsis

    Article • Pediatric Drugs, November 2013, Springer Science + Business Media

    Dr Catherine Sherwin

  75. A Neonatal Amikacin Covariate Model Can Be Used to Predict Ontogeny of Other Drugs Eliminated Through Glomerular Filtration in Neonates

    Article • Pharmaceutical Research, September 2013, Springer Science + Business Media

    Professor karel allegaert , Dr Catherine Sherwin

  76. Fundamentals of Population Pharmacokinetic Modelling

    Article • Clinical Pharmacokinetics, September 2012, Springer Science + Business Media

    Dr Catherine Sherwin

  77. Fundamentals of Population Pharmacokinetic Modelling

    Article • Clinical Pharmacokinetics, September 2012, Springer Science + Business Media

    Dr Catherine Sherwin

  78. Fundamentals of Population Pharmacokinetic Modelling

    Article • Clinical Pharmacokinetics, August 2012, Springer Science + Business Media

    Dr Catherine Sherwin

  79. Fundamentals of Population Pharmacokinetic Modelling

    Article • Clinical Pharmacokinetics, August 2012, Springer Science + Business Media

    Dr Catherine Sherwin

  80. Individualised dosing of amikacin in neonates

    Article • European Journal of Clinical Pharmacology, August 2009, Springer Science + Business Media

    Dr Catherine Sherwin

  81. Discrepancies between predicted and observed rates of intravenous gentamicin delivery for neonates

    Article • Journal of Pharmacy and Pharmacology, April 2009, Wiley

    Dr Catherine Sherwin

  82. Individualising netilmicin dosing in neonates

    Article • European Journal of Clinical Pharmacology, August 2008, Springer Science + Business Media

    Dr Catherine Sherwin

  83. A simple binding assay for the direct determination of biotin in urine

    Article • Clinica Chimica Acta, October 2005, Elsevier

    Dr Catherine Sherwin